Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s…
Poised to disrupt sciences sample preparation market estimated at $6 billion Nearly 300 patented enabling technology platform products installed at more than 150 sites worldwide Two patents awarded in China for Ultra Shear Technology used…
Largest mini-casino operator in Washington Increasing revenues and profits Better odds than betting in a casino Americans love casino gambling. In near record numbers, over 81 million people visited U.S. casinos in the 12-month period…
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://dtn.fm/tQo00). IGC is…
China will see nearly $2 trillion in new consumer-driven consumption by 2021 Moxian facilitates Chinese consumer consumption Tweaked business model positions Moxian for more rapid expansion China’s overall economic growth has slowed from its nearly…
STLHF adds 6,000 more acres to its Bristol Dry Lake Lithium Project, and aims to be a significant low-cost, domestic producer of battery-grade lithium materials Electric cars and smart phones use ion-lithium rechargeable batteries —…
Licensed Canadian cannabis cultivation company Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) recently entered into a collaboration and licensing agreement with Canntab Therapeutics Limited to collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and…
Seeks patent on new therapy for drug that employs concentrations of THC Data for drug candidate IGC-AD1 finds that it reduces buildup of ‘senior plaque’ without causing death of neurons, which can lead to memory…
Canadian energy exploration and development company Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) this morning offered an update on its exploration and process testing program at its Bristol Dry Lake lithium brine projected…
Global financial technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) this morning announced that its Aptito subsidiary will exhibit at the 2017 Florida Restaurant & Lodging Show scheduled to take place from October…
UnionPay module in Moxian+ User and Moxian+ Business apps gives access for potential joint venture partners to China’s largest payment processor Hao Qing Hu named as new company president and CEO in addition to Moxian…
Exploration of Bristol Lake Project reveals excellent lithium-bearing brine harvest potential Global lithium compounds market projected to reach U.S. $5.87 billion by 2020 Technological advances provide access to low cost, battery-grade lithium materials World demand…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines…
Encouraging results noted for pancreatitis patients with exocrine pancreatic insufficiency Early data shows favorable safety profile, positive dose tolerance Favorable trends observed in other identified markers Study is being performed at four sites in Australia…
Within the global market, consumer trends are ever tending toward the utilization of mobile devices when making purchases and otherwise connecting with businesses—something seen particularly among Chinese consumers. Well aware of China’s cashless trend, Moxian,…
In response to compelling recent data, India Globalization Capital, Inc. (NYSE MKT: IGC) announced it has made a highly significant novel breakthrough in treating Alzheimer’s disease with tetrahydrocannabinol (THC)—an advancement that could potentially bring much-needed…
Nearly half of consumers in China pay using mobile devices Three-quarters of online payments come through mobile accounts Moxian’s apps serve consumers and businesses in the O2O market The current trends in the global market…
Product portfolio to include drugs and supplements Faster monetization of lead Alzheimer’s candidate as supplement Market valuation poised to soar It should come as no surprise to discover that the medical cannabis dispensary product line…
The rise of the sharing economy model and gig economy, empowered by mobile IT and big data, has rapidly transformed an antiquated labor market, where the average independent worker often ended up dependent on temp…
A recent Global Mobile Money Report by Nielsen (http://dtn.fm/7rflL) shows that almost half of Chinese consumers will likely use a mobile device to make payments in restaurants, bars and retail stores—a much higher number than…
Four drug candidates in the pipeline Potential sales of Alzheimer’s drugs run to billions Hyalolex heading for clinical trials India Globalization Capital, Inc. (NYSE MKT: IGC) is racing ahead with its preparation of medical trials…
Director nominees include Liu Shu Juan, CEO of Shewn International Group and financial controller of Shanghai Shewn Wine Co. Moxian is expected to formalize joint venture agreement with Shewn International Group by end of September…
Travel and technology company Monaker Group, Inc. (OTCQB: MKGI) this morning announced that it has been invited to present at the Third Annual Robins Equity Research Roundup, which is scheduled to take place September 26-27…
Provider of mobile payment tools Using social media to drive ecommerce Marketplace that links offline and online A look at Nielsen’s latest Global Mobile Money Report (http://dtn.fm/C8SXf) shows that Moxian, Inc. (NASDAQ: MOXC) is in…
IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines…
In an effort to expand more rapidly in China, Moxian, Inc. (NASDAQ: MOXC) has shifted the focus of its joint venture strategy, including the agreement with Shewn International Group of Shanghai. An excerpt of an…
More than 5.3 million people in the U.S. have Alzheimer’s disease, which has no effective cure or substantial treatment India Globalization Capital’s IGC-ADI drug candidate targets proteins associated with the buildup of lesions in the…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced compelling in vitro data compiled from genetically engineered cell lines showing that, at…
Crystal Equity Research, encouraged by new joint venture strategy, forecasts rising revenue for Moxian (http://dtn.fm/Q8Fva) Key to market growth is UnionPay’s payment module in Moxian+ app MOXC now targets larger $2-4 million businesses for Moxian+…
Travel and technology company Monaker Group, Inc. (OTCQB: MKGI) this morning announced that it has divested certain non-core assets for total consideration of $2.9 million. Additionally, the company has completed the conversion of $1.4 million…
Non-bank payment processing at $1.2 trillion, with 12.8% CAGR forecast through 2021 Large bank takeovers already underway NETE operating the right business in the right sector at the right time Savvy investors always look to…
Alzheimer’s is the most expensive disease in the United States, and pharmaceutical companies are racing to find viable treatments for this devastating disease, which currently affects more than 5.3 million Americans and their loved ones.…
Crystal Equity Research maintains $5.25 price target for Moxian 75% upside from current price Price appreciation could be even higher depending on paid user conversions Crystal Equity Research published a research report on Moxian, Inc.…
Hyalolex for Alzheimer’s and other cannabis-based drugs for pain, epilepsy, and more are raising the market valuation growth potential for IGC Phytocannabinoids target protein receptors in the brain, peripheral nervous system and other parts of…
Nasdaq Hearings Panel grants decision on listing based on shareholder equity and minimum bid issues, conditional on NETE providing evidence of compliance by October 20, 2017 NETE says impact of its cost cutting program should…
2017 second quarter net revenues up 18 percent to $16.1 million PayOnline, a flexible e-commerce payment solutions platform, launches in U.S. Net Element is strategically poised for growth in the U.S. and emerging countries Mobile-based…
Alzheimer’s is America’s most expensive disease, with a new diagnosis every 66 seconds IGC’s unique use of marijuana extracts in combination therapy for potential Alzheimer’s breakthrough shows promise Low market cap could make IGC a…
In January 2017, Crystal Equity Research LLC published an initial report on Moxian, Inc. (NASDAQ: MOXC) with a price target of $5.25, and that price target remains unchanged as of an August 15 updated report…